IDH1 and central nervous system cancer: Although the number of examined cases were relatively low, they all consisted of patients who were admitted to a single center (Fujita Health University); thus, these patients were followed continuously, enabling us to demonstrate novel radiological patterns in recurrent IDH mutant gliomas and their association with genetic information.